Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Apple
AAPL
|
+$121M |
| 2 |
Carnival Corp
CCL
|
+$115M |
| 3 |
eBay
EBAY
|
+$63.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$60.5M |
| 5 |
Philip Morris
PM
|
+$58.9M |
Top Sells
| 1 |
NetEase
NTES
|
+$89.3M |
| 2 |
TSMC
TSM
|
+$62.2M |
| 3 |
PayPal
PYPL
|
+$43.5M |
| 4 |
Iron Mountain
IRM
|
+$32.3M |
| 5 |
Lam Research
LRCX
|
+$26.8M |
Sector Composition
| 1 | Technology | 28.15% |
| 2 | Healthcare | 13.9% |
| 3 | Consumer Discretionary | 12.2% |
| 4 | Communication Services | 11.64% |
| 5 | Financials | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MON
276
DELISTED
Monsanto Co
MON
| $9.67M | 0.07% |
94,610
-15,265
| -14% | -$1.56M |
|
277
T Rowe Price
TROW
$23.8B
| $9.54M | 0.07% |
143,380
-10,104
| -7% | -$672K |
|
278
Urban Edge Properties
UE
$2.66B
| $9.52M | 0.07% |
338,402
-72,992
| -18% | -$2.05M |
|
279
RTX Corp
RTX
$206B
| $9.47M | 0.07% |
148,173
| – | – |
|
|
HES
280
DELISTED
Hess
HES
| $9.38M | 0.07% |
174,932
+56,765
| +48% | +$3.04M |
|
281
Pentair
PNR
$18.1B
| $9.37M | 0.07% |
217,077
+32,069
| +17% | +$1.38M |
|
282
Eli Lilly
LLY
$662B
| $9.36M | 0.07% |
116,702
+20,913
| +22% | +$1.68M |
|
283
Boeing
BA
$175B
| $8.95M | 0.07% |
67,929
-6,347
| -9% | -$836K |
|
284
US Bancorp
USB
$75.7B
| $8.83M | 0.07% |
205,796
| – | – |
|
285
Biogen
BIIB
$20.7B
| $8.79M | 0.06% |
28,074
-1,911
| -6% | -$598K |
|
286
Goldman Sachs
GS
$225B
| $8.69M | 0.06% |
53,896
+4,004
| +8% | +$646K |
|
287
Sabra Healthcare REIT
SBRA
$4.6B
| $8.69M | 0.06% |
345,355
-29,839
| -8% | -$751K |
|
|
STAY
288
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $8.52M | 0.06% |
+600,000
| New | +$8.52M |
|
|
CONE
289
DELISTED
CyrusOne Inc Common Stock
CONE
| $8.32M | 0.06% |
174,980
+6,686
| +4% | +$318K |
|
290
Thermo Fisher Scientific
TMO
$184B
| $8.2M | 0.06% |
51,546
-1,768
| -3% | -$281K |
|
291
W.W. Grainger
GWW
$47.7B
| $8.16M | 0.06% |
36,267
-25,794
| -42% | -$5.8M |
|
292
Texas Instruments
TXN
$169B
| $8.11M | 0.06% |
115,528
-6,495
| -5% | -$456K |
|
|
WPX
293
DELISTED
WPX Energy, Inc.
WPX
| $8.1M | 0.06% |
614,315
+197,667
| +47% | +$2.61M |
|
|
ALXN
294
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $8.01M | 0.06% |
65,395
-3,501
| -5% | -$429K |
|
295
Mondelez International
MDLZ
$80.1B
| $8.01M | 0.06% |
182,479
-8,029
| -4% | -$352K |
|
296
Occidental Petroleum
OXY
$44.7B
| $7.89M | 0.06% |
108,205
-79,948
| -42% | -$5.83M |
|
297
Bristol-Myers Squibb
BMY
$95.1B
| $7.81M | 0.06% |
144,812
-55,431
| -28% | -$2.99M |
|
298
American International
AIG
$43.6B
| $7.67M | 0.06% |
129,290
-9,007
| -7% | -$534K |
|
|
VASC
299
DELISTED
Vascular Solutions Inc
VASC
| $7.44M | 0.05% |
154,323
+95,824
| +164% | +$4.62M |
|
300
Crown Holdings
CCK
$11B
| $7.39M | 0.05% |
129,481
-1,843
| -1% | -$105K |
|